| Product Code: ETC11316185 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market - Industry Life Cycle |
3.4 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market - Porter's Five Forces |
3.5 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume Share, By Packaging Type, 2021 & 2031F |
3.7 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about cholera and its prevention measures in Mexico |
4.2.2 Government initiatives to improve vaccination coverage |
4.2.3 Rising incidences of cholera outbreaks in Mexico |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas |
4.3.2 High cost associated with the vaccine |
4.3.3 Concerns regarding the safety and efficacy of the vaccine |
5 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Trends |
6 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market, By Types |
6.1 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Oral Vaccines, 2021 - 2031F |
6.1.4 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Injectable Vaccines, 2021 - 2031F |
6.1.5 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Combination Vaccines, 2021 - 2031F |
6.2 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market, By Packaging Type |
6.2.1 Overview and Analysis |
6.2.2 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Vials, 2021 - 2031F |
6.2.3 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Ampoules, 2021 - 2031F |
6.2.4 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Pre-filled Syringes, 2021 - 2031F |
6.3 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Specialty Pharmacies, 2021 - 2031F |
6.3.4 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Healthcare Facilities, 2021 - 2031F |
6.4.3 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Government Immunization Programs, 2021 - 2031F |
6.4.4 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
7 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Import-Export Trade Statistics |
7.1 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Export to Major Countries |
7.2 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Imports from Major Countries |
8 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage in Mexico |
8.2 Number of cholera cases reported annually |
8.3 Adoption rate of recombinant b subunit cholera vaccine in Mexico |
9 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market - Opportunity Assessment |
9.1 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Opportunity Assessment, By Packaging Type, 2021 & 2031F |
9.3 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market - Competitive Landscape |
10.1 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenue Share, By Companies, 2024 |
10.2 Mexico Whole Cell Cholera Vaccine Recombinant B Subunit Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here